Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07005804

Calcium Pyrophosphate Deposition (CPPD) Disease

Calcium Pyrophosphate Deposition (CPPD) Disease : Clinical and Paraclinical Profile, Gene Expression and Metabolomics of the Acute and Chronic Clinical Phenotype

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
137 (estimated)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to describe the transcriptomic and metabolomic profile of patients with chronic Calcium Pyrophosphate Deposition (CPPD) compared to those with acute CPPD. The hypotheses are as follows : * It is hypothesised that there is a transcriptomic and metabolomic signature of CPPD which explains why therapeutic responses to different anti-inflammatory treatments differ from one phenotype to another one * It is hypothesised that the acute and chronic clinical phenotypes of CPPD have different clinical, biological and imaging characteristics, as well as a differing predisposition toward crystalline deposition and inflammatory pathway activation. The management of participants with chronic forms of the disease included in this research was modelled on the usual recommended management, including a biological workup, joint puncture, ultrasound and radiographic workup. Double-energy CT scans and transcriptomic and metabolomic analyses on plasma are not routine tests.

Conditions

Interventions

TypeNameDescription
GENETICtranscriptomic and metabolomic analysisVenous blood samples for transcriptomic and metabolomic analysis will be taken in 3 x 4 mL ethylenediaminetetraacetic acid (EDTA) tubes and stored immediately at 4°C, before being cryopreserved at -80°C in 500 μL aliquots of plasma. In addition, for transcriptomic analysis, a sample will also be taken in a Paxgen RNA tube cryopreserved at -80°C.

Timeline

Start date
2025-10-01
Primary completion
2027-05-01
Completion
2027-11-01
First posted
2025-06-05
Last updated
2025-06-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07005804. Inclusion in this directory is not an endorsement.

Calcium Pyrophosphate Deposition (CPPD) Disease (NCT07005804) · Clinical Trials Directory